| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 May 2024 | 22 Apr 2024 |
| LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 ,inter alia, to consider and approve audited financial results of the Company for the quarter and year-ended March 31, 2024 and recommend dividend, if any. Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31, 2024 And Recommend Final Dividend @ 400% i.e. Rs. 8/- Per Equity Share Of The Face Value of Rs. 2/- Each For The Year Ended March 31, 2024. Appointment of Mr. Jeffrey Kindler and Mr. Alfonso Zulueta as Independent Directors of the Company effective May 6, 2024. (As Per BSE Announcement Dated on: 06/05/2024) | ||
| Board Meeting | 22 Mar 2024 | 22 Mar 2024 |
| The Company plans to carve out, its trade generics business in India, as a going concern, on a slump sale basis, to Lupin Life Sciences Limited, wholly owned subsidiary of the Company. | ||
| Board Meeting | 7 Feb 2024 | 24 Jan 2024 |
| LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine-months ended December 31 2023. Unaudited Financial Results for the quarter and nine-months ended December 31, 2023. (As per BSE Announcement Dated on 07/02/2024) | ||
| Board Meeting | 8 Nov 2023 | 25 Oct 2023 |
| LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter and half-year ended September 30 2023 and other business matters. Unaudited Financial Results for the quarter and half-year ended September 30, 2023. (As per BSE Announcement Dated on 08/11/2023) | ||
| Board Meeting | 3 Aug 2023 | 21 Jul 2023 |
| LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2023 and other business matters. LUPIN LIMITED has informed BSE about Board Meeting to be held on 03 Aug 2023 to consider financial statements for the period ended June 2024. Financial results / Other business. (As Per BSE Announcement Dated on 22/07/2023) | ||
According to the terms of the agreement, Lupin may receive up to $84 million in total payment based on future dependent milestones.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.
The inspection finished with no observations, and the facility was classified as "No Action Indicated" (NAI).
Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
